The April 16 Drug Utilization Review Board and April 17 Pharmacy and Therapeutics Committee Meetings will not be done as in-person meetings due to COVID-19 concerns. Both meetings will be conducted through audio visual conferencing and call in methods. More information including access for the public will be published here closer to the meeting dates.
The goal of the Idaho Medicaid Pharmacy Program is to provide quality care to Medicaid participants with the most effective drug at the right price.
Magellan Medicaid Administration, Inc. is the Idaho Medicaid Pharmacy Benefit Management contractor.
Provider Line (Physicians/Pharmacies): (800) 922-3987
Participant Line: (888) 773-9466
Available 24 hours/day, 7 days/week
The Idaho Department of Health and Welfare has contracted with Magellan Health Services, through it’s subsidiary, Provider Synergies, LLC, to provide consultation and support for the Department’s Pharmacy and Therapeutics Committee (P&T Committee) and the Department’s Preferred Drug List (PDL) Program.
The state of Idaho is a member of the Drug Effectiveness Review Project (DERP). DERP is a collaboration of public entities (the Center for Evidence-based Policy and the Oregon Evidence-based Practice Center) who have joined together to produce systematic, evidence-based reviews of the comparative effectiveness and safety of drugs in many widely used drug classes.
The Department of Health and Welfare has contracted with Myers and Stauffer LC, a national consulting firm, to provide assistance in establishing and maintaining an Actual Acquisition Cost (AAAC) for medications.
Phone: (800) 591-1183
Fax: (317) 571-8481